Literature DB >> 4905148

Antibody levels detected by the fluorescent antibody technique in mice infected with Plasmodium vinckei and P. chabaudi.

F E Cox, C A Crandall, S A Turner.   

Abstract

The malaria parasites of mice are convenient models for immunological studies. Plasmodium vinckei and P. chabaudi are similar parasites which behave differently in mice, the former invariably being fatal whereas the latter seldom kills the host. The experiments described in this paper were performed in order to compare the antibody levels in the Ig, IgM and IgG serum fractions in mice cured of P. vinckei infections and naturally recovered from P. chabaudi. The technique involved using specific labelled antimouse-Ig, -IgM and -IgG sera and had not previously been applied to malaria infections. The results showed that the patterns of antibody production were similar in cured and naturally recovered mice. IgG antibodies were involved from an early stage of the infection and IgM antibodies persisted throughout the period of experiment and even after challenge. These results are significant in that they indicate a pattern of immune response different from the classically accepted one and draw attention to the fact that even in highly immune animals considerable amounts of IgM may be present.

Entities:  

Mesh:

Year:  1969        PMID: 4905148      PMCID: PMC2427425     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  12 in total

1.  FLUORESCENT ANTIBODY METHODS AND THEIR USE IN MALARIA RESEARCH.

Authors:  A VOLLER
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA.I. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM MALARIAE.

Authors:  W E COLLINS; G M JEFFERY; J C SKINNER
Journal:  Am J Trop Med Hyg       Date:  1964-01       Impact factor: 2.345

3.  DETECTION OF MALARIA ANTIBODIES--IMMUNODIAGNOSIS.

Authors:  J E TOBIE
Journal:  Am J Trop Med Hyg       Date:  1964-01       Impact factor: 2.345

4.  A comparison of complement-fixation and fluorescent antibody methods in a longitudinal study of simian malaria infection.

Authors:  R Schindler; A Voller
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

5.  Immunofluorescence and humoral immunity to Plasmodium berghei.

Authors:  A Voller
Journal:  Ann Soc Belges Med Trop Parasitol Mycol       Date:  1965

6.  Macroglobulin antibody response to Ascaris suum infection. A comparison of precipitating antibody in rats and mice.

Authors:  C A Crandall; R B Crandall
Journal:  Exp Parasitol       Date:  1967-12       Impact factor: 2.011

7.  Fluorescent antibody staining. 3. Preparation of fluorescein-isothiocyanate-labeled antibodies.

Authors:  B T Wood; S H Thompson; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

8.  Acquired immunity to Plasmodium vinckei in mice.

Authors:  F E Cox
Journal:  Parasitology       Date:  1966-11       Impact factor: 3.234

9.  Cross-immunity between the malaria parasites of rodents.

Authors:  F E Cox; A Voller
Journal:  Ann Trop Med Parasitol       Date:  1966-09

10.  Serological cross-reaction between rodent malaria parasites as determined by the indirect immunofluorescent technique.

Authors:  H M el-Nahal
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

View more
  3 in total

1.  Antigenic relationships between the malaria parasites and piroplasms of mice as determined by the fluorescent-antibody technique.

Authors:  F E Cox; S A Turner
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

2.  The specificity of immunoglobulin G and immunoglobulin M in the fluorescent-antibody test for malaria parasites in mice.

Authors:  F E Cox
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

3.  Protection of mice against haemoprotozoan Babesia microti with Brucella abortus strain 19.

Authors:  E Herod; I A Clark; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.